La saliva como alternativa para la detección de drogas de abuso: una revisión sistemática de la literatura

ilustraciones, graficas

Autores:
Hernandez Tilaguy, Lorena Sofia
Tipo de recurso:
Fecha de publicación:
2022
Institución:
Universidad Nacional de Colombia
Repositorio:
Universidad Nacional de Colombia
Idioma:
spa
OAI Identifier:
oai:repositorio.unal.edu.co:unal/81634
Acceso en línea:
https://repositorio.unal.edu.co/handle/unal/81634
https://repositorio.unal.edu.co/
Palabra clave:
610 - Medicina y salud::614 - Medicina Forense; incidencia de lesiones, heridas, enfermedades; medicina preventiva pública
Pruebas de Toxicidad
Toxicity Tests
Saliva
Drogas ilicitas
Diagnostico
Análisis
Detección de abuso de sustancias
Saliva
Illicit drugs
Diagnosis
Analysis
Substance abuse detection
Rights
openAccess
License
Reconocimiento 4.0 Internacional
id UNACIONAL2_5bebb182703d9a5776f397b160ece442
oai_identifier_str oai:repositorio.unal.edu.co:unal/81634
network_acronym_str UNACIONAL2
network_name_str Universidad Nacional de Colombia
repository_id_str
dc.title.spa.fl_str_mv La saliva como alternativa para la detección de drogas de abuso: una revisión sistemática de la literatura
dc.title.translated.eng.fl_str_mv Saliva as an alternative for the detection of drugs of abuse: a systematic review of the literature
title La saliva como alternativa para la detección de drogas de abuso: una revisión sistemática de la literatura
spellingShingle La saliva como alternativa para la detección de drogas de abuso: una revisión sistemática de la literatura
610 - Medicina y salud::614 - Medicina Forense; incidencia de lesiones, heridas, enfermedades; medicina preventiva pública
Pruebas de Toxicidad
Toxicity Tests
Saliva
Drogas ilicitas
Diagnostico
Análisis
Detección de abuso de sustancias
Saliva
Illicit drugs
Diagnosis
Analysis
Substance abuse detection
title_short La saliva como alternativa para la detección de drogas de abuso: una revisión sistemática de la literatura
title_full La saliva como alternativa para la detección de drogas de abuso: una revisión sistemática de la literatura
title_fullStr La saliva como alternativa para la detección de drogas de abuso: una revisión sistemática de la literatura
title_full_unstemmed La saliva como alternativa para la detección de drogas de abuso: una revisión sistemática de la literatura
title_sort La saliva como alternativa para la detección de drogas de abuso: una revisión sistemática de la literatura
dc.creator.fl_str_mv Hernandez Tilaguy, Lorena Sofia
dc.contributor.advisor.none.fl_str_mv Chaves Silva, Diana Carolina
dc.contributor.author.none.fl_str_mv Hernandez Tilaguy, Lorena Sofia
dc.contributor.researchgroup.spa.fl_str_mv Sustancias Psicoactivas
dc.subject.ddc.spa.fl_str_mv 610 - Medicina y salud::614 - Medicina Forense; incidencia de lesiones, heridas, enfermedades; medicina preventiva pública
topic 610 - Medicina y salud::614 - Medicina Forense; incidencia de lesiones, heridas, enfermedades; medicina preventiva pública
Pruebas de Toxicidad
Toxicity Tests
Saliva
Drogas ilicitas
Diagnostico
Análisis
Detección de abuso de sustancias
Saliva
Illicit drugs
Diagnosis
Analysis
Substance abuse detection
dc.subject.other.spa.fl_str_mv Pruebas de Toxicidad
dc.subject.other.eng.fl_str_mv Toxicity Tests
dc.subject.proposal.spa.fl_str_mv Saliva
Drogas ilicitas
Diagnostico
Análisis
Detección de abuso de sustancias
dc.subject.proposal.eng.fl_str_mv Saliva
Illicit drugs
Diagnosis
Analysis
Substance abuse detection
description ilustraciones, graficas
publishDate 2022
dc.date.accessioned.none.fl_str_mv 2022-06-28T16:31:58Z
dc.date.available.none.fl_str_mv 2022-06-28T16:31:58Z
dc.date.issued.none.fl_str_mv 2022
dc.type.spa.fl_str_mv Trabajo de grado - Maestría
dc.type.driver.spa.fl_str_mv info:eu-repo/semantics/masterThesis
dc.type.version.spa.fl_str_mv info:eu-repo/semantics/acceptedVersion
dc.type.content.spa.fl_str_mv Text
dc.type.redcol.spa.fl_str_mv http://purl.org/redcol/resource_type/TM
status_str acceptedVersion
dc.identifier.uri.none.fl_str_mv https://repositorio.unal.edu.co/handle/unal/81634
dc.identifier.instname.spa.fl_str_mv Universidad Nacional de Colombia
dc.identifier.reponame.spa.fl_str_mv Repositorio Institucional Universidad Nacional de Colombia
dc.identifier.repourl.spa.fl_str_mv https://repositorio.unal.edu.co/
url https://repositorio.unal.edu.co/handle/unal/81634
https://repositorio.unal.edu.co/
identifier_str_mv Universidad Nacional de Colombia
Repositorio Institucional Universidad Nacional de Colombia
dc.language.iso.spa.fl_str_mv spa
language spa
dc.relation.references.spa.fl_str_mv Accioni, F., Nieddu, M., Corona, P., & Boatto, G. (2020). Hexanol-Based Supramolecular Solvents Tool for the Determination of 11 Illicit Phenethylamines in Oral Fluid by LC-MS/MS. Journal of Analytical Toxicology, 44(1), 15–21. https://doi.org/10.1093/jat/bkz039
Agencia Mundial Antidopaje. (2018). La lista de Prohibiciones. https://www.wada-ama.org/sites/default/files/prohibited_list_2018_sp.pdf%0Ahttps://cv.udl.cat/access/content/group/102716-1617/MERITXELL/2016-10-28_wada_prohibited_list_2017_sp_final.pdf
Agencia Mundial Antidopaje. (2022). El codigo mundial antidopaje, estandar internacional, La lista de prohibiciones. 1–10. https://www.wada-ama.org/sites/default/files/prohibited_list_2018_sp.pdf
Álamo, C., Zaragozá Arnáez, C., Noriega Matanza, C., & Torres, L. M. (2017). Fentanilo: una molécula y múltiples formulaciones galénicas de trascendencia clínica en el tratamiento del dolor irruptivo oncológico. Revista de La Sociedad Espanola Del Dolor, 24(4), 188–200. https://doi.org/10.20986/resed.2017.3586/2017
Alcaldía de Bogotá, UNODC, Cicad, & OEA. (2016). Estudio de consumo de sustancias psicoactivas en Bogotá D.C 2016. http://www.odc.gov.co/Portals/1/publicaciones/pdf/consumo/estudios/locales/CO031052016-estudio-consumo-sustancias-psicoactivas-bogota-2016.pdf
Alcohol and Drug Foundation. (2021). Roadside drug testing. https://adf.org.au/insights/roadside-drug-testing/
Allen, K. R. (2011). Screening for drugs of abuse: Which matrix, oral fluid or urine? Annals of Clinical Biochemistry, 48(6), 531–541. https://doi.org/10.1258/acb.2011.011116
Alvarado, E. (2017). La Marihuana en Toxicología Forense. Slideshare. https://es.slideshare.net/agustinarenas1/la-marihuana-toxicologa-forense-74407203
Amaratunga, P., Lorenz, B., & Lemberg, D. (2013). Quantitative measurement of synthetic cathinones in oral fluid. Journal of Analytical Toxicology, 37(9), 622–628. https://doi.org/10.1093/jat/bkt080
Andas, H., Krabseth, H. M., Enger, A., Marcussen, B., Haneborg, A. M., Christophersen, A., Vindenes, V., & Øiestad, E. (2014). Detection time for thc in oral fluid after frequent cannabis smoking. Therapeutic Drug Monitoring, 36(6), 808–814. https://doi.org/10.1097/FTD.0000000000000092
Angulo, G. B., & Aurora Hernández Sánchez. (2016). Utilidad de las muestras de saliva en el diagnóstico por el laboratorio. Rev Latinoam Patol Clin Med Lab, 63(1), 13–18. www.medigraphic.com/patologiaclinicawww.medigraphic.org.mxwww.medigraphic.org.mx
Anizan, S., & Huestis, M. (2012). The Potential Role of Oral Fluid in Antidoping Testing. Nature Medicine, 17(7), 883–887. https://doi.org/10.1373/clinchem.2013.209676.
Anizan, S., Milman, G., Desrosiers, N., Barnes, A. J., David, A., & Huestis, M. A. (2014). Oral fluid cannabinoid concentrations following controlled smoked cannabis in chronic frequent and occasional smokers. 405(26), 1–19. https://doi.org/10.1007/s00216-013-7291-5.Oral
Arizan, S., Bergamaschi, M., Barnes, A. J., Milman, G., Desrosiers, N. A., Lee, D., Gorelick, D. A., & Huestis, M. A. (2016). Impact of Oral Fluid Collection Device on Cannabinoid Stability Following Smoked Cannabis. Drug Testing and Analysis, 7(2), 114–120. https://doi.org/10.1002/dta.1688.AH
Arkell, T. R., Kevin, R. C., Stuart, J., Lintzeris, N., Haber, P. S., Ramaekers, J. G., & McGregor, I. S. (2019). Detection of Δ9 THC in oral fluid following vaporized cannabis with varied cannabidiol (CBD) content: An evaluation of two point-of-collection testing devices. Drug Testing and Analysis, 11(10), 1486–1497. https://doi.org/10.1002/dta.2687
Arroyo, A., Mora, A., Sanchez, M., Barbal, M., & Palahi, M. (2011). Times of Detection of Drugs of Abuse in Saliva: Study of Arrested Population. Journal of Forensic Research, 02(01), 10–13. https://doi.org/10.4172/2157-7145.1000114
Arroyo Fernández, A., Mora Font, A., Sánchez Fité, M., Barbal Pagés, M., & Palahí Adroher, M. (2010). Drogas de abuso en saliva de conductores: aspectos médico-legales. Revista Española de Medicina Legal, 34(1), 3–10. https://doi.org/10.1016/s0377-4732(08)70020-8
Bakke, E., Høiseth, G., Furuhaugen, H., Berg, T., Arnestad, M., & Gjerde, H. (2020). Oral Fluid to Blood Concentration Ratios of Different Psychoactive Drugs in Samples from Suspected Drugged Drivers. Therapeutic Drug Monitoring, 42(5), 795–800. https://doi.org/10.1097/FTD.0000000000000760
Barnes, A. J., Scheidweiler, K. B., Kolbrich-Spargo, E. A., Gorelick, D. A., Goodwin, R. S., & Huestis, M. A. (2011). MDMA and metabolite disposition in expectorated oral fluid after controlled oral MDMA administration. Therapeutic Drug Monitoring, 33(5), 602–608. https://doi.org/10.1097/FTD.0b013e3182281975
Barquero, M. (2006). Principios y Aplicaciones de la Cromatografía de Gases. Universidad de Costa Rica. https://books.google.com.co/books?id=g3o_PUTmr3wC&printsec=frontcover&dq=cromatografia+de+gases&hl=es-419&sa=X&ved=0ahUKEwiglovJkc_kAhWI1lkKHQdXAbUQ6AEIKTAA#v=onepage&q=cromatografia de gases&f=false
Barwick, V., Morrillas, P., Ellison, S., & Engman, J. (1990). La Adecuación al Uso de los Métodos Analíticos. In Eurachem (Vol. 56, Issue 6).
Bassotti, E., Merone, G. M., D’Urso, A., Savini, F., Locatelli, M., Tartaglia, A., Dossetto, P., D’Ovidio, C., & de Grazia, U. (2020). A new LC-MS/MS confirmation method for the determination of 17 drugs of abuse in oral fluid and its application to real samples. Forensic Science International, 312. https://doi.org/10.1016/j.forsciint.2020.110330
Bista, S. R., Haywood, A., Norris, R., Good, P., Tapuni, A., Lobb, M., & Hardy, J. (2015). Saliva versus Plasma for Pharmacokinetic and Pharmacodynamic Studies of Fentanyl in Patients with Cancer. Clinical Therapeutics, 37(11), 2468–2475. https://doi.org/10.1016/j.clinthera.2015.09.002
Böttcher, M., Lierheimer, S., Peschel, A., & Beck, O. (2019). Detection of heroin intake in patients in substitution treatment using oral fluid as specimen for drug testing. Drug and Alcohol Dependence, 198(February), 136–139. https://doi.org/10.1016/j.drugalcdep.2019.02.011
Bruun, L. D., Kjeldstadli, K., Temte, V., Birdal, M., Bachs, L., Langødegård, M., Strand, D. H., Gaare, K. I., Øiestad, E., & Høiseth, G. (2019). Detection time of oxazepam and zopiclone in urine and oral fluid after experimental oral dosing. Journal of Analytical Toxicology, 43(5), 369–377. https://doi.org/10.1093/jat/bky083
Bueno, G., & Salazar, J. (2012). Validación del método para el análisis de cocaína, opiaceos y sus principales adulterantes por Cromatografía de gases acoplado a espectrometria de masas (GC-MS), en el Instituto Nacional de Medicina Legal de Ciencias Forenses. In UNIVERSIDAD TECNOLOGICA DE PEREIRA. http://recursosbiblioteca.utp.edu.co/tesisd/textoyanexos/66028423B928.pdf
Busardo, F. P., Pichini, S., Pellegrini, M., Montana, A., lo Faro, A. F., Zaami, S., & Graziano, S. (2017). Correlation between Blood and Oral Fluid Psychoactive Drug Concentrations and Cognitive Impairment in Driving under the Influence of Drugs. Current Neuropharmacology, 16(1), 84–96. https://doi.org/10.2174/1570159x15666170828162057
Calvin, G., & Roy, K. (2017). Liquid Chromatography. Britannica. https://www.britannica.com/science/chromatography/Liquid-chromatography
Cardenas, K. (2012). PERFIL CLÍNICO Y DEMOGRÁFICO DE PACIENTES ATENDIDOS EN LOS SERVICIOS DE URGENCIAS, POR INTOXICACIÓN AGUDA CON SUSTANCIAS PSICOACTIVAS. BOGOTÁ D.C. JULIO 2010 – JUNIO 2011.Universidad Nacional de Colombia.
Casadiego Mesa, A. F., & Lastra Bello, S. M. (2015). Cannabis sintético: aspectos toxicológicos, usos clínicos y droga de diseño. Revista de La Facultad de Medicina, 63(3), 501–510. https://doi.org/10.15446/revfacmed.v63n3.47460
Chow, A. T. Y., Ng, V. C. H., & Lau, F. L. (2015). Can “oral fluid” be used instead of “urine” for rapid screening of drug of abuse: A prospective pilot study. Hong Kong Journal of Emergency Medicine
Christodoulides, N., de La Garza, R., Simmons, G. W., McRae, M. P., Wong, J., Newton, T. F., Smith, R., Mahoney, J. J., Hohenstein, J., Gomez, S., Floriano, P. N., Talavera, H., Sloan, D. J., Moody, D. E., Andrenyak, D. M., Kosten, T. R., Haque, A., & McDevitt, J. T. (2015). Application of programmable bio-nano-chip system for the quantitative detection of drugs of abuse in oral fluids. Drug and Alcohol Dependence, 153, 306–313. https://doi.org/10.1016/j.drugalcdep.2015.04.026
Codigo sustantivo del trabajo. (1993). 1(August), 117–125.
Concheiro, M., Newmeyer, M., Costa, J. L., Flegel, R., Gorelick, D. A., & Huestis, M. A. (2016). Morphine and Codeine in Oral Fluid after Controlled Poppy Seed Administration Marta. Drug Testing and Analysis, 176(1), 100–106. https://doi.org/10.1002/dta.1742.Morphine
Cone, E. J., & Huestis, M. A. (2007). Interpretation of oral fluid tests for drugs of abuse. Annals of the New York Academy of Sciences, 1098, 51–103. https://doi.org/10.1196/annals.1384.037
Congreso de Colombia. (2002). Ley 734 de 2002. 2002. https://www.alcaldiabogota.gov.co/sisjur/normas/Norma1.jsp?i=4589
Congreso de la República de Colombia. (2003). Ley 845 del 2003. Diario Oficial, 2003(45), 10.
Corte Constitucional de Colombia. (2019). Sentencia C-253-19. http://www.corteconstitucional.gov.co/relatoria/2019/C-253-19.htm
Cortez, R. (2000). Cromatografía de gases. SGPWE. http://sgpwe.izt.uam.mx/files/users/uami/jrvc/QA_II/Cromatografia_de_Gases.pdf
Coulter, C. A., & Moore, C. M. (2019). Analysis of drugs in oral fluid using LC-MS/MS. In Methods in Molecular Biology (Vol. 1872, pp. 237–259). Humana Press Inc. https://doi.org/10.1007/978-1-4939-8823-5_22
Crouch, D. J., Day, J., Baudys, J., & Fatah, A. A. (2005). Evaluation of Saliva/Oral Fluid as an Alternate Drug Testing Specimen. Departament of Justice US. https://www.ojp.gov/pdffiles1/nij/grants/203569.pdf
Dayong, L., Erin, K., Garry, M., Allan, B., Robert, G., & Huestis, M. A. (2013). Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration? Early Human Development, 83(1), 1–11. https://doi.org/10.1016/j.drugalcdep.2012.10.011
de Castro, A., Lendoiro, E., Fernández-Vega, H., López-Rivadulla, M., Steinmeyer, S., & Cruz, A. (2014). Assessment of different mouthwashes on cannabis oral fluid concentrations. Drug Testing and Analysis, 6(10), 1011–1019. https://doi.org/10.1002/dta.1605
Decreto 1844. (2018). https://www.funcionpublica.gov.co/eva/gestornormativo/norma.php?i=88843
Desrosiers, N. A., Barnes, A. J., Hartman, R. L., Scheidweiler, K. B., Kolbrich-Spargo, E. A., Gorelick, D. A., Goodwin, R. S., & Huestis, M. A. (2013). Oral Fluid and Plasma 3,4-Methylenedioxymethamphetamine (MDMA) and Metabolite Correlation after Controlled Oral MDMA Administration. Anal Bioanal Chem, 405(12), 4067–4076. https://doi.org/10.1007/s00216-013-6848-7.Oral
Desrosiers, N. A., Ramaekers, J. G., Chauchard, E., Gorelick, D. A., & Huestis, M. A. (2015). Smoked Cannabis’ Psychomotor and Neurocognitive Effects in Occasional and Frequent Smokers. Journal of Analytical Toxicology, 39(4), 251–261. https://doi.org/10.1093/jat/bkv012
di Corcia, D., Lisi, S., Pirro, V., Gerace, E., Salomone, A., & Vincenti, M. (2013). Determination of pharmaceutical and illicit drugs in oral fluid by ultra-high performance liquid chromatography-tandem mass spectrometry. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 927, 133–141. https://doi.org/10.1016/j.jchromb.2013.01.025
di Fazio, V., Wille, S. M. R., Toennes, S. W., van Wel, J. H. P., Ramaekers, J. G., & Samyn, N. (2018). Driving under the influence of cocaine: Quantitative determination of basic drugs in oral fluid obtained during roadside controls and a controlled study with cocaine users. Drug Testing and Analysis, 10(8), 1285–1296. https://doi.org/10.1002/dta.2379
Direccion General de Seguridad Vial. (2015). Programa Control de Drogas. Buenos Aires Argentina. https://www.buenosaires.gob.ar/areas/seguridad_justicia/seguridad_urbana/seguridad_vial/programa_control_drogas.php?menu_id=34134
Drummer, O. H. (2016). Drug Testing in Oral Fluid. Psychological Perspectives, 59(4), 524–525. https://doi.org/10.1080/00332925.2016.1240547
Dyer, K. R., & Wilkinson, C. (2008). The detection of illicit drugs in oral fluid: Another potential strategy to reduce illicit drug-related harm. Drug and Alcohol Review, 27(1), 99–107. https://doi.org/10.1080/09595230701727583
Egea-Mellado, J. M. (2010). Fundamento de la espectrometria de masas en tándem (MS/MS). Sociedad Española de Bioquímica Clínica y Patología Molecular, 1–11.
Ellefsen, K., Concheiro, M., Pirard, S., Gorelick, D. A., & Huestis, M. (2016). Oral Fluid Cocaine and Benzoylecgonine Concentrations following Controlled Intravenous Cocaine Administration. Forensic Science International, 260(1), 95–101.
El tiempo. (2015). Aumenta consumo de drogas en el trabajo. El Tiempo. https://www.eltiempo.com/archivo/documento/CMS-14674817
Fabritius, M., Chtioui, H., Battistella, G., Annoni, J., Dao, K., Favrat, B., Fornari, E., Luer, E., Maeder, P., & Giroud, C. (2013). Comparasion of cannabinoid concentrations in oral fluid and whole blood between occasional and regular cannabis smokers prior to and after smoking a cannabis joint. Anal Bioanal Chem, 405, 9791–9803.
Fenoll, C., Muñoz, J., Sanchiz, V., Herreros, B., Hernandez, V., Minguez, M., & Benages, A. (2004). Unstimulated salivary flow rate, pH and buffer capacity of saliva in healthy volunteers. Resvista Española de Enfermedades Digestivas, 96(11), 773–783. https://pdfs.semanticscholar.org/6313/5f811d748f67a5ad01604c19de67d1eb3443.pdf
Fiorentin, T. R., D’Avila, F. B., Comiran, E., Zamboni, A., Scherer, J. N., Pechansky, F., Borges, P. E. M., Fröehlich, P. E., & Limberger, R. P. (2017). Simultaneous determination of cocaine/crack and its metabolites in oral fluid, urine and plasma by liquid chromatography-mass spectrometry and its application in drug users. Journal of Pharmacological and Toxicological Methods, 86(April), 60–66. https://doi.org/10.1016/j.vascn.2017.04.003
Franco, A., Navarro, M., Campos, M., Blumenberg, C., Alves, A., & Paranhos, L. (2020). Assessment of dental age estimation methods applied to Brazilian children a systematic review and metaanalysis DMFR. https://doi.org/10.1259/dmfr.20200128
Gainza, I., Nogué, S., Martínez Velasco, C., Hoffman, R. S., Burillo-Putze, G., Dueñas, A., Gómez, J., & Pinillos, M. A. (2003). Intoxicación por drogas. Anales Del Sistema Sanitario de Navarra, 26. https://doi.org/10.4321/s1137-66272003000200006
Gaohua, L., Miao, X., & Dou, L. (2021). Crosstalk of physiological pH and chemical pKa under the umbrella of physiologically based pharmacokinetic modeling of drug absorption, distribution, metabolism, excretion, and toxicity. In Expert Opinion on Drug Metabolism and Toxicology (Vol. 17, Issue 9, pp. 1103–1124). Taylor and Francis Ltd. https://doi.org/10.1080/17425255.2021.1951223
Garg, U., & Cooley, C. (2019). Testing of Drugs of Abuse in Oral Fluid, Sweat, Hair, and Nail: Analytical, Interpretative, and Specimen Adulteration Issues. In Critical Issues in Alcohol and Drugs of Abuse Testing (Second Edi). Elsevier Inc. https://doi.org/10.1016/b978-0-12-815607-0.00028-9
Gjerde, H., Langel, K., Favretto, D., & Verstraete, A. G. (2014). Detection of 4 benzodiazepines in oral fluid as biomarker for presence in blood. Therapeutic Drug Monitoring, 36(2), 252–256. https://doi.org/10.1097/FTD.0b013e3182a3ab42
Gobierno de Buenos Aires. (2010). Programa de control de drogas. https://www.buenosaires.gob.ar/areas/seguridad_justicia/seguridad_urbana/seguridad_vial/programa_control_drogas.php?menu_id=34134
González-Luque, J. C., & Quintela-Jorge, O. (2011). La determinación de drogas en fluido oral en conductores de vehículos: ¿se abre el camino a la intervención preventiva? Rev Esp Drogodep, 36(3), 341–350.
Griswold, M. K., Chai, P. R., Krotulski, A. J., Friscia, M., Chapman, B. P., Varma, N., Boyer, E. W., Logan, B. K., & Babu, K. M. (2017). A Novel Oral Fluid Assay (LC-QTOF-MS) for the Detection of Fentanyl and Clandestine Opioids in Oral Fluid After Reported Heroin Overdose. Journal of Medical Toxicology, 13(4), 287–292. https://doi.org/10.1007/s13181-017-0632-6
Hartman, R. L., Brown, T. L., Milavetz, G., Spurgin, A., Gorelick, D. A., Gaffney, G., & Huestis, M. A. (2016). Controlled vaporized cannabis, with and without alcohol: subjective effects and oral fluid-blood cannabinoid relationships. Drug Testing and Analysis, 8(7), 690–701. https://doi.org/10.1002/dta.1839
Heltsley, R., DePriest, A., Black, D. L., Crouch, D. J., Robert, T., Marshall, L., Meadors, V. M., Caplan, Y. H., & Cone, E. J. (2012). Oral fluid drug testing of chronic pain patients. II. Comparison of paired oral fluid and urine specimens. Journal of Analytical Toxicology, 36(2), 75–80. https://doi.org/10.1093/jat/bkr019
Hofman, L. F. (2001). Human Saliva as a Diagnostic Specimen. The Journal of Nutrition, 131(5), 1621S-1625S. https://doi.org/10.1093/jn/131.5.1621S
IDEAM. (2021). Instructivo de confirmación o validación de métodos analíticos. 2013–2015. http://sgi.ideam.gov.co/documents/412030/35488871/M-S-LC-I038+INSTRUCTIVO+DE+CONFIRMACIÓN+O+VALIDACIÓN+DE+MÉTODOS+ANALÍTICOS+v3.pdf/cd82e785-16f2-4ffa-b965-4614a9808f38?version=1.0
Instituto Nacional de Medicina Legal y Ciencias Forenses. (2015). Guía para la determinación clínica forense del estado de embriaguez aguda. 91. http://www.medicinalegal.gov.co/documents/20143/40473/Guía+para+la+determinación+clínica+forense+delestado+de+embriaguez+aguda.pdf/8de54a98-38db-f7c1-e04c-9b2505b585e9
J.M, A., Diaz, J., Castello, J., Fabregat, A., & Lopez, P. (2002). Drogas de abuso: evaluación de las unidades de conductas adictivas en un Área Sanitaria. Revista de Diagnóstico Biológico, 51(2). https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0034-79732002000200005
Kaufman, E., & Lamster, I. B. (2002). The diagnostic applications of Saliva A Review. Critical Reviews in Oral Biology & Medicine, 13(2), 197–212. https://doi.org/10.1177/154411130201300209
Krotulski, A. J., Mohr, A. L. A., Friscia, M., & Logan, B. K. (2018). Field Detection of Drugs of Abuse in Oral Fluid Using the Alere DDS2 Mobile Test System with Confirmatios by Liquids Chromatography Tandem Mass Spectrometry (LC-MS/MS). Jorunal of Analytical Toxicology, 170–175.
K.Wolff, M. Farrell, J.Marsden, M. G. Monteiro, R. Ali, S. W. y J. S. (2001). Revisión de los indicadores biológicos de uso ilegal de drogas, consideraciones prácticas y utilidad clínica. Revista de Toxicomanías, 28. http://www.cat-barcelona.com/app/webroot/uploads/rets/RET28_1.pdf
Langel, K., Gjerde, H., Favretto, D., Lillsunde, P., Øiestad, E. L., Ferrara, S. D., & Verstraete, A. G. (2014). Comparison of drug concentrations between whole blood and oral fluid. Drug Testing and Analysis, 6(5), 461–471. https://doi.org/10.1002/dta.1532
Langel, K., Gunnar, T., Ariniemi, K., Rajamäki, O., & Lillsunde, P. (2011). A validated method for the detection and quantitation of 50 drugs of abuse and medicinal drugs in oral fluid by gas chromatography-mass spectrometry. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 879(13–14), 859–870. https://doi.org/10.1016/j.jchromb.2011.02.027
Lee, D., Milman, G., Barnes, A. J., Goodwin, R. S., Hirvonen, J., & Huestis, M. A. (2011). Oral fluid cannabinoids in chronic, daily cannabis smokers during sustained, monitored abstinence. Clinical Chemistry, 57(8), 1127–1136. https://doi.org/10.1373/clinchem.2011.164822
Lee, D., Milman, G., Schwope, D. M., Barnes, A. J., Gorelick, D. A., & Huestis, M. A. (2012). Cannabinoid Stability in Authentic Oral Fluid after Controlled Cannabis Smoking. Clinical Chemistry, 23(1), 1–7. https://doi.org/10.1373/clinchem.2012.184929.Cannabinoid
Lee, D., Schwope, D. M., Milman, G., Barnes, A. J., Gorelick, D. A., & Huestis, M. A. (2012). Cannabinoid Disposition in Oral Fluid after Controlled Smoked Cannabis. Clinical Chemistry, 23(1), 1–7. https://doi.org/10.1373/clinchem.2011.177881.Cannabinoid
Lee, D., Vandrey, R., Milman, G., Bergamaschi, M., Mendu, D. R., Murray, J. A., Barnes, A. J., & Huestis, M. A. (2013). Oral fluid/plasma cannabinoid ratios following controlled oral THC and smoked cannabis administration. Anal Bioanal Chem, 405(23), 7269–7279. https://doi.org/10.1007/s00216-013-7159-8.Oral
Ley 769 de 2002. (2002). http://www.secretariasenado.gov.co/senado/basedoc/ley_0769_2002.html
Logan, B. K., D’Orazio, A. L., Mohr, A. L. A., Limoges, J. F., Miles, A. K., Scarneo, C. E., Kerrigan, S., Liddicoat, L. J., Scott, K. S., & Huestis, M. A. (2018). Recommendations for toxicological investigation of drug-impaired driving and motor vehicle fatalities-2017 update. Journal of Analytical Toxicology, 42(2), 63–68. https://doi.org/10.1093/jat/bkx082
Logan, B. K., Mohr, A. L. A., & Talpins, S. K. (2014). Detection and prevalence of drug use in arrested drivers using the dräger drug test 5000 and affiniton DrugWipe oral fluid drug screening devices. Journal of Analytical Toxicology, 38(7), 444–450. https://doi.org/10.1093/jat/bku050
López V, A., Aroche A., A., & Romero, B. R. (2010). Uso y abuso de las benzodiacepinas. MEDISAN, 14(4), 555–566.
Lund, H. M. E., Øiestad, E. L., Gjerde, H., & Christophersen, A. S. (2011). Drugs of abuse in oral fluid collected by two different sample kits - Stability testing and validation using ultra performance tandem mass spectrometry analysis. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 879(30), 3367–3377. https://doi.org/10.1016/j.jchromb.2011.09.002
MacCall, C. A., Ritchie, G., & Sood, M. (2013). Oral fluid testing as an alternative to urine testing for drugs of abuse in inpatient forensic settings: Giving patients choice. Scottish Medical Journal, 58(2), 99–103. https://doi.org/10.1177/0036933013482640
Mateu-Gelabert, P., Friedman, S., & Sandoval, M. (2007). Éxtasis (3,4-metilendioximetanfetamina, MDMA): aspectos farmacológicos, clínicos y criminológicos. Trastornos Adictivos, 9(4), 260–268. http://www.ncbi.nlm.nih.gov/pubmed/21915175
Miller, B., Kim, J., & Concheiro, M. (2017). Stability of synthetic cathinones in oral fluid samples. Forensic Science International, 274, 13–21. https://doi.org/10.1016/j.forsciint.2016.11.034
Milman, G., Schwope, D. M., Schwilke, E. W., Darwin, W. D., Deanna, L., Goodwin, R. S., Gorelick, D. A., & Huestis, M. A. (2013). Oral Fluid and Plasma Cannabinoid Ratios after Around-the- Clock Controlled Oral Δ9-Tetrahydrocannabinol Administration. Clinical Chemistry, 57(11). https://doi.org/10.1373/clinchem.2011.169490.Oral
Moore, C. (2011). Oral fluid and hair in workplace drug testing programs: New technology for immunoassays. Drug Testing and Analysis, 3(3), 166–168. https://doi.org/10.1002/dta.140
Moore, C., Coulter, C., Uges, D., Tuyay, J., van der Linde, S., van Leeuwen, A., Garnier, M., & Orbita, J. (2011). Cannabinoids in oral fluid following passive exposure to marijuana smoke. Forensic Science International, 212(1–3), 227–230. https://doi.org/10.1016/j.forsciint.2011.06.019
Musshoff, F., Hokamp, E. G., Bott, U., & Madea, B. (2014). Performance evaluation of on-site oral fluid drug screening devices in normal police procedure in Germany. Forensic Science International, 238, 120–124. https://doi.org/10.1016/j.forsciint.2014.02.005
National Conference Of State Legislatures. (2021). States Explore Oral Fluid Testing to Combat Impaired Driving. https://www.ncsl.org/research/transportation/states-explore-oral-fluid-testing-to-combat-impaired-driving.aspx
NCI thesaurus. (2022). Cocaine. https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=NCI_Thesaurus&code=C80153
Newmeyer, M., Concheiro, M., Costa, J. L., Flegel, R., Gorelick, D. A., & Huestis, M. A. (2016). Oral Fluid with Three Modes of Collection and Plasma Methamphetamine and Amphetamine Enantiomer Concentrations After Controlled Intranasal l-Methamphetamine Administration Matthew. Drug Testing and Analysis, 176(3), 139–148. https://doi.org/10.1002/dta.1784.
Newmeyer, M., Desrosiers, N., Dayong, L., Mendu, D., BBarnes, A., Gorelick, D. A., & Hue. (2014). Cannabinoid Disposition in Oral Fluid after Controlled Cannabis Smoking in Frequent and Occasional Smokers. Drug and Alcohol Review, 23(1), 1–7. https://doi.org/10.1002/dta.1632.
Nichterwitz, J., Fiorentin, T., Viera, T., Pereira, R., & Pechansky, F. (2017). Oral fluid testing for cocaine: Analytical evaluation of two point-of-collection drug screening Devices. Journal of Analytical Toxicology, 41(5), 392–398. https://doi.org/10.1093/jat/bkx018
Nordal, K., Øiestad, E. L., Enger, A., Christophersen, A. S., & Vindenes, V. (2015). Detection Times of Diazepam, Clonazepam, and Alprazolam in Oral Fluid Collected from Patients Admitted to Detoxification, after High and Repeated Drug Intake. Therapeutic Drug Monitoring, 37(4), 451–460. https://doi.org/10.1097/FTD.0000000000000174
NZ Drug Foundation. (2022). New drug-driving law ignores science, targets poor . https://www.drugfoundation.org.nz/matters-of-substance/new-drug-driving-law-ignores-science-targets-poor/
Observatorio de drogas de Colombia. (2017). Reporte de Drogas en Colombia. http://www.odc.gov.co/Portals/1/publicaciones/pdf/odc-libro-blanco/reporte_drogas_colombia_2017.pdf
Observatorio Nacional de Seguridad Vial. (2017). La embriaguez al conducir, descripcion de una problematica vigente en Colombia. https://ansv.gov.co/observatorio/public/documentos/embriaguez 2017 - bavaria (jun_2018_final).pdf
OECD (2010). Drugs and Driving Detection and Deterrence. https://www.itf-oecd.org/sites/default/files/docs/10drugs.pdf
Organización Panamericana de la Salud. (2022). Abuso de sustancias. https://www.paho.org/es/temas/abuso-sustancias
Ospina, L. (1994). El método de análisis para los estudios de estabilidad y de biodisponibilidad de medicamentos. Parte I. Revista Colombiana de Ciencias Quimico-Farmaceuticas, 22.
Palmela Pereira, C. (2014). A importância médico-legal e criminalística da saliva: Sistematização da sua aplicação nas ciências forenses. Revista Portuguesa de Estomatologia, Medicina Dentaria e Cirurgia Maxilofacial, 55(1), 3–6. https://doi.org/10.1016/j.rpemd.2014.01.002
Papaseit, E., Olesti, E., Pérez-Mañá, C., Torrens, M., Fonseca, F., Grifell, M., Ventura, M., de la Torre, R., & Farré, M. (2021). Acute pharmacological effects of oral and intranasal mephedrone: An observational study in humans. Pharmaceuticals, 14(2), 1–13. https://doi.org/10.3390/ph14020100
Pehrsson, A., Blencowe, T., Vimpari, K., Langel, K., Engblom, C., & Lillsunde, P. (2011). An evaluation of on-site oral fluid drug screening devices drugwipe® 5+ and rapid STAT® using oral fluid for confirmation analysis. Journal of Analytical Toxicology, 35(4), 211–218. https://doi.org/10.1093/anatox/35.4.211
Petrides, A. K., Melanson, S. E. F., Kantartjis, M., Le, R. D., Demetriou, C. A., & Flood, J. G. (2018). Monitoring opioid and benzodiazepine use and abuse: Is oral fluid or urine the preferred specimen type? Clinica Chimica Acta, 481(December 2017), 75–82. https://doi.org/10.1016/j.cca.2018.02.034
Pichini, S., Altieri, I., Zuccaro, P., & Pacifici, R. (1996). Drug monitoring in nonconventional biological fluids and matrices. Clinical Pharmacokinetics, 30(3), 211–228. https://doi.org/10.2165/00003088-199630030-00003
Pinzon, A. (2015). Aspectos técnicos y científicos de las pruebas de campo para la detección de sustancias psicoactivas aplicadas a conductores de vehículos autmotores. Instituto Nacional de medicina legal y ciencias forenses. https://www.medicinalegal.gov.co/documents/20143/49508/Art%C3%ADculos%C2%B7Complementarios.pdf
Poyatos, L., Papaseit, E., Olesti, E., Pérez-Mañá, C., Ventura, M., Carbón, X., Grifell, M., Fonseca, F., Torrens, M., de la Torre, R., & Farré, M. (2021). A comparison of acute pharmacological effects of methylone and mdma administration in humans and oral fluid concentrations as biomarkers of exposure. In Biology (Vol. 10, Issue 8). https://doi.org/10.3390/biology10080788
PubChem. (2015a). Alprazolam. National Center for Biotechnology Information. https://pubchem.ncbi.nlm.nih.gov/compound/2118#section=Metabolism-Metabolites
Pubchem. (2015). Cocaine. National Center for Biotechnology Information. https://pubchem.ncbi.nlm.nih.gov/compound/446220
PubChem. (2015b). Dronabidol. National Center for Biotechnology Information. https://pubchem.ncbi.nlm.nih.gov/compound/16078
Puy, C. L. (2006). La saliva en el mantenimiento de la salud oral y como ayuda en el diagnóstico de algunas patologías. Medicina Oral, Patología Oral y Cirugía Bucal (Internet), 11(5), 449–455.
Ramos Maya, A. (2017). Proyecto de Ley 167 del 2017 (Issue 3). http://leyes.senado.gov.co/proyectos/index.php/textos-radicados-senado/p-ley-2017-2018/1059-proyecto-de-ley-167-de-2017
Rocchi, R., Simeoni, M. C., Montesano, C., Vannutelli, G., Curini, R., Sergi, M., & Compagnone, D. (2018). Analysis of new psychoactive substances in oral fluids by means of microextraction by packed sorbent followed by ultra-high-performance liquid chromatography–tandem mass spectrometry. Drug Testing and Analysis, 10(5), 865–873. https://doi.org/10.1002/dta.2330
ROSITA. (2018a). Retriever September 26, 2019, from http://www.rosita.org/success-program-random-roadside-testing/
ROSITA. (2018b). Retriever September 26, 2019, from http://www.rosita.org/better-reliable-roadside-drug-test/
Saar-Reismaa, P., Erme, E., Vaher, M., Kulp, M., Kaljurand, M., & Mazina-Šinkar, J. (2018). In Situ Determination of Illegal Drugs in Oral Fluid by Portable Capillary Electrophoresis with Deep UV Excited Fluorescence Detection. Analytical Chemistry, 90(10), 6253–6258. https://doi.org/10.1021/acs.analchem.8b00911
Sanchez Martinez, P. (2013). La saliva como fluido diagnóstico. Enfermedades Hepáticas Autoinmunes, 7(Unidad de Inmunología, Facultad de Medicina, Universidad de Granada, Granada), 44–52.
Scherer, J. N., Fiorentin, T. R., Borille, B. T., Pasa, G., Sousa, T. R. V., von Diemen, L., Limberger, R. P., & Pechansky, F. (2017). Reliability of point-of-collection testing devices for drugs of abuse in oral fluid: A systematic review and meta-analysis. Journal of Pharmaceutical and Biomedical Analysis, 143, 77–85. https://doi.org/10.1016/j.jpba.2017.05.021
Schulze, H., Schumacher, M., Urmeew, R., Alvarez, J., Bernhoft, I. M., de Gier, H. G., Hagenzieker, M., Houwing, S., Knoche, A., & Pilgerstorfer, M. (2012). Driving Under the Influence of Drugs, Alcohol and Medicines in Europe—findings from the DRUID project. 1–58.
Shafi, A., Berry, A. J., Sumnall, H., Wood, D. M., & Tracy, D. K. (2020). New psychoactive substances: a review and updates. Therapeutic Advances in Psychopharmacology, 10, 204512532096719. https://doi.org/10.1177/2045125320967197
Sobczak, L., & Gorynski, K. (2021). Evaluation of swabs form 15 commercially available oral fluid sample collection devices for the analysis of commonly aused substances: doping agents and drugs of abuse. The Royal Society of Chemistry, 145, 7279–7288.
Spindle, T. R., Cone, E. J., Herrmann, E. S., Mitchell, J. M., Flegel, R., LoDico, C., Bigelow, G. E., & Vandrey, R. (2020). Pharmacokinetics of cannabis brownies: A controlled examination of Δ9-tetrahydrocanna-binol and metabolites in blood and oral fluid of healthy adult males and females. Journal of Analytical Toxicology, 44(7), 661–671. https://doi.org/10.1093/jat/bkaa067
Spindle, T. R., Cone, E. J., Schlienz, N. J., Mitchell, J. M., Bigelow, G. E., Flegel, R., Hayes, E., & Vandrey, R. (2019). Acute pharmacokinetic profile of smoked and vaporized cannabis in human blood and oral fluid. Journal of Analytical Toxicology, 43(4), 233–258. https://doi.org/10.1093/jat/bky104
Swortwood, M., Newmeyer, M., Andersson, M., Abulseud, O., Scheidweiler, K. B., & Huestis, M. A. (2017). Cannabinoid disposition in oral fluid after controlled smoked, vaporized, and oral cannabis administration. Drug Testing and Analysis, 176(3), 139–148. https://doi.org/10.1002/dta.2092
Tang, M. H. Y., Ching, C. K., Poon, S., Chan, S. S. S., Ng, W. Y., Lam, M., Wong, C. K., Pao, R., Lau, A., & Mak, T. W. L. (2018). Evaluation of three rapid oral fluid test devices on the screening of multiple drugs of abuse including ketamine. Forensic Science International, 286, 113–120. https://doi.org/10.1016/j.forsciint.2018.03.004
Téllez, J. (2013). Marihuana cannabis: aspectos toxicológicos, clínicos, sociales y potenciales usos terapéuticos. In Journal of Chemical Information and Modeling (Vol. 53, Issue 9). https://doi.org/10.1017/CBO9781107415324.004
Toennes, S. W., Geraths, A., Pogoda, W., Paulke, A., Wunder, C., Theunissen, E. L., & Ramaekers, J. G. (2018). Pharmacokinetic properties of the synthetic cannabinoid JWH-018 in oral fluid after inhalation. Drug Testing and Analysis, 10(4), 644–650. https://doi.org/10.1002/dta.2310
Toennes, S. W., Schneider, D., Pogoda, W., Paulke, A., Wunder, C., Theunissen, E. L., Kuypers, K. P. C., de Sousa Fernandes Perna, E., & Ramaekers, J. G. (2019). Pharmacokinetic properties of 4-fluoroamphetamine in serum and oral fluid after oral ingestion. Drug Testing and Analysis, 11(7), 1028–1034. https://doi.org/10.1002/dta.2595
Trana, A. di, Mannocchi, G., Pirani, F., Maida, N. la, Via, S., Cooperazione, D., & Addiction, C. (2020). A Comprehensive HPLC – MS-MS Screening Method for 77 New Psychoactive Substances , 24 Classic Drugs and 18 Related Metabolites in Blood , Urine and Oral Fluid. Department of Excellence of Biomedical Sciences and Public Health.
Truver, M. T., Palmquist, K. B., & Swortwood, M. J. (2019). Oral fluid and drug impairment: Pairing toxicology with drug recognition expert observations. Journal of Analytical Toxicology, 43(8), 637–643. https://doi.org/10.1093/jat/bkz075
United Nations. (2021). Informe Mundial de Drogas. In World Drug Report 2021. https://www.unodc.org/res/wdr2021/field/WDR21_Booklet_2.pdf
UNODC. (2017). Resumen informe mundial sobre las drogas 2017. https://www.unodc.org/wdr2017/field/WDR_Booklet1_Exsum_Spanish.pdf
UNODC. (2021). What are NPS? https://www.unodc.org/LSS/Page/NPS
Uribe Granja, C., Saavedra, M. Á., Almarales Navarro, J. R., Cabezas Pulido, L. E., & Soto Bohórquez, P. V. (2012). Accidentalidad vial por consumo de drogas y alcohol: estado actual. Revista Repertorio de Medicina y Cirugía, 21(2), 79–86. https://doi.org/10.31260/repertmedcir.v21.n2.2012.800
Valen, A., Leere Øiestad, Å. M., Strand, D. H., Skari, R., & Berg, T. (2017). Determination of 21 drugs in oral fluid using fully automated supported liquid extraction and UHPLC-MS/MS. Drug Testing and Analysis, 9(5), 808–823. https://doi.org/10.1002/dta.2045
Vandrey, R., Herrmann, E. S., Mitchell, J. M., Bigelow, G. E., Flegel, R., LoDico, C., & Cone, E. J. (2017). Pharmacokinetic profile of oral cannabis in humans: Blood and oral fluid disposition and relation to pharmacodynamic outcomes. Journal of Analytical Toxicology, 41(2), 83–99. https://doi.org/10.1093/jat/bkx012
Vanstechelman, S., Isalberti, C., van der Linden, T., Pil, K., Legrand, S. A., & Verstraete, A. G. (2012). Analytical evaluation of four on-site oral fluid drug testing devices. Journal of Analytical Toxicology, 36(2), 136–140. https://doi.org/10.1093/jat/bkr016
Verstraete, A., & Ghent University. (2010). Roadside Testing Assessment. The Cambridge Companion to Bunyan, 1–10. https://doi.org/10.1017/CCOL9780521515269.001
VIM. (2012). Vocabulario Internacional de Metrologia Conceptos fundamentales y generales, y terminos asociados. Journal of the American Chemical Society, 54(2), 580–583. https://doi.org/10.1021/ja01341a021
Vindenes, V., Lund, H. M. E., Andresen, W., Gjerde, H., Ikdahl, S. E., Christophersen, A. S., & Øiestad, E. L. (2012). Detection of drugs of abuse in simultaneously collected oral fluid, urine and blood from Norwegian drug drivers. Forensic Science International, 219(1–3), 165–171. https://doi.org/10.1016/j.forsciint.2012.01.001
Vindenes, V., Strand, D. H., Koksæter, P., & Gjerde, H. (2016). Detection of nitrobenzodiazepines and their 7-amino metabolites in oral fluid. Journal of Analytical Toxicology, 40(4), 310–312. https://doi.org/10.1093/jat/bkw020
Vindenes, V., Yttredal, B., Oiestad, E., Waal, H., & Bernard, J. (2011). Oral fluid is aviable alternative for monitoring drug abuse: Detection of drugs in oral fluid by liquid chromatography-tandem mass spectrometry and comparison to the results from urine samples from patients treated with methadone or buprenorphine. Journal of Analytical Toxicology, 35(1), 32–39.
Vizcaino, G. (2017). Importancia del calculo de la sensibilidad, especificidad y otros parámetros estadísticos en el uso de las pruebas de diagnostico clínico y laboratorio. Medicina y Laboratorio, 23(7–8), 365–386. http://docs.bvsalud.org/biblioref/2018/05/883697/importancia-calculo-sensibilidad-y-especifidad.pdf
Zaragoza Meneses, Ma. T. de J. (2018). La saliva. Auxiliar de diagnóstico. In La saliva. Auxiliar de diagnóstico. https://doi.org/10.22201/fesz.9786070299780e.2018
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.license.spa.fl_str_mv Reconocimiento 4.0 Internacional
dc.rights.uri.spa.fl_str_mv http://creativecommons.org/licenses/by/4.0/
dc.rights.accessrights.spa.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv Reconocimiento 4.0 Internacional
http://creativecommons.org/licenses/by/4.0/
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.extent.spa.fl_str_mv xvi, 112 páginas
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Universidad Nacional de Colombia
dc.publisher.program.spa.fl_str_mv Bogotá - Medicina - Maestría en Toxicología
dc.publisher.department.spa.fl_str_mv Departamento de Toxicología
dc.publisher.faculty.spa.fl_str_mv Facultad de Medicina
dc.publisher.place.spa.fl_str_mv Bogotá, Colombia
dc.publisher.branch.spa.fl_str_mv Universidad Nacional de Colombia - Sede Bogotá
institution Universidad Nacional de Colombia
bitstream.url.fl_str_mv https://repositorio.unal.edu.co/bitstream/unal/81634/1/1026581820.2022.pdf
https://repositorio.unal.edu.co/bitstream/unal/81634/2/license.txt
https://repositorio.unal.edu.co/bitstream/unal/81634/3/1026581820.2022.pdf.jpg
bitstream.checksum.fl_str_mv a428bdf1822ae6a10e585967106d51c6
8153f7789df02f0a4c9e079953658ab2
26c391958f84ae6b2bd16c358278265a
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Institucional Universidad Nacional de Colombia
repository.mail.fl_str_mv repositorio_nal@unal.edu.co
_version_ 1806886085456822272
spelling Reconocimiento 4.0 Internacionalhttp://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2Chaves Silva, Diana Carolina20e776318a9d5628459c32150f5783c2Hernandez Tilaguy, Lorena Sofia6ae17d62e5f6d47a308c040e98b938c1Sustancias Psicoactivas2022-06-28T16:31:58Z2022-06-28T16:31:58Z2022https://repositorio.unal.edu.co/handle/unal/81634Universidad Nacional de ColombiaRepositorio Institucional Universidad Nacional de Colombiahttps://repositorio.unal.edu.co/ilustraciones, graficasEl incremento en el consumo de drogas de abuso es una problemática mundial que afecta negativamente, no solo a la persona que decide consumir sino también a su entorno, la gran dificultad social que desencadena dicho consumo estimula a la comunidad científica a investigar sobre metodologías que ayuden a la detección de dichas sustancias. La detección de drogas de abuso en saliva es un tema que no cuenta con información detallada y consensuada, presentándose la necesidad de dar a conocer dichas metodologías con el fin de aportar evidencia científica que pueda ser usada en diferentes ámbitos poblacionales. El presente estudio tuvo como objetivo evaluar mediante una revisión sistemática los parámetros de desempeño analítico que presentan las pruebas de detección de drogas de abuso en saliva, mediante una búsqueda en las bases de datos: Pubmed, Scielo, Scopus, CINALH, Cochrane library, Redalyc y Doaj,, se tuvieron en cuenta artículos científicos (de tipo experimental, in vitro, in vivo, poblacional) con estudios de las drogas de abuso clásicas como: THC, cocaína, anfetaminas, benzodiacepinas y sobre nuevas sustancias psicoactivas. Se incluyeron 69 artículos de los últimos 10 años en los resultados y discusión donde se abarcó la toxicocinética de las drogas en saliva, se comparó dicha toxicocinética con otras matrices de análisis, se abarcaron los métodos de detección y los factores que influyen en la detección. Se concluye que la saliva es de utilidad en la detección de las drogas de abuso estudiadas tras un consumo agudo, sin embargo, se debe tener en cuenta diferentes variables que influyen en la detección de cada tipo de droga. (Texto tomado de la fuente)The increase in the consumption of drugs of abuse is a global problem that adversely affects not only the person who decides to consume but also their environment, the great social difficulty that triggers such consumption stimulates the scientific community to investigate methodologies that help to the detection of these substances. The detection of drugs of abuse in saliva it is a topic that does not have detailed and consensual information, presenting the need to publicize these methodologies to provide scientific evidence that can be used in different population settings. The objective of this study was to evaluate, through a systematic review, the analytical performance parameters presented by the tests for the detection of drugs of abuse in saliva, through a search in the following databases: Pubmed, Scielo, Scopus, CINALH, Cochrane library, Redalyc and Doaj,, scientific articles (experimental, in vitro, in vivo, population) were taken into account with studies of classic drugs of abuse such as: THC, cocaine, amphetamines, benzodiazepines and on novel psychoactive substances. 69 articles from the last 10 years were included in the results and discussion where the toxicokinetic of drugs in saliva were covered, said toxicokinetic was compared with other analysis samples, detection methods and factors that influence detection were covered. It is concluded that saliva is useful in the detection of drugs of abuse studied after acute consumption, however, different variables that influence the detection of each type of drug must be considered.MaestríaMagíster en ToxicologíaSustancias Psicoactivasxvi, 112 páginasapplication/pdfspaUniversidad Nacional de ColombiaBogotá - Medicina - Maestría en ToxicologíaDepartamento de ToxicologíaFacultad de MedicinaBogotá, ColombiaUniversidad Nacional de Colombia - Sede Bogotá610 - Medicina y salud::614 - Medicina Forense; incidencia de lesiones, heridas, enfermedades; medicina preventiva públicaPruebas de ToxicidadToxicity TestsSalivaDrogas ilicitasDiagnosticoAnálisisDetección de abuso de sustanciasSalivaIllicit drugsDiagnosisAnalysisSubstance abuse detectionLa saliva como alternativa para la detección de drogas de abuso: una revisión sistemática de la literaturaSaliva as an alternative for the detection of drugs of abuse: a systematic review of the literatureTrabajo de grado - Maestríainfo:eu-repo/semantics/masterThesisinfo:eu-repo/semantics/acceptedVersionTexthttp://purl.org/redcol/resource_type/TMAccioni, F., Nieddu, M., Corona, P., & Boatto, G. (2020). Hexanol-Based Supramolecular Solvents Tool for the Determination of 11 Illicit Phenethylamines in Oral Fluid by LC-MS/MS. Journal of Analytical Toxicology, 44(1), 15–21. https://doi.org/10.1093/jat/bkz039Agencia Mundial Antidopaje. (2018). La lista de Prohibiciones. https://www.wada-ama.org/sites/default/files/prohibited_list_2018_sp.pdf%0Ahttps://cv.udl.cat/access/content/group/102716-1617/MERITXELL/2016-10-28_wada_prohibited_list_2017_sp_final.pdfAgencia Mundial Antidopaje. (2022). El codigo mundial antidopaje, estandar internacional, La lista de prohibiciones. 1–10. https://www.wada-ama.org/sites/default/files/prohibited_list_2018_sp.pdfÁlamo, C., Zaragozá Arnáez, C., Noriega Matanza, C., & Torres, L. M. (2017). Fentanilo: una molécula y múltiples formulaciones galénicas de trascendencia clínica en el tratamiento del dolor irruptivo oncológico. Revista de La Sociedad Espanola Del Dolor, 24(4), 188–200. https://doi.org/10.20986/resed.2017.3586/2017Alcaldía de Bogotá, UNODC, Cicad, & OEA. (2016). Estudio de consumo de sustancias psicoactivas en Bogotá D.C 2016. http://www.odc.gov.co/Portals/1/publicaciones/pdf/consumo/estudios/locales/CO031052016-estudio-consumo-sustancias-psicoactivas-bogota-2016.pdfAlcohol and Drug Foundation. (2021). Roadside drug testing. https://adf.org.au/insights/roadside-drug-testing/Allen, K. R. (2011). Screening for drugs of abuse: Which matrix, oral fluid or urine? Annals of Clinical Biochemistry, 48(6), 531–541. https://doi.org/10.1258/acb.2011.011116Alvarado, E. (2017). La Marihuana en Toxicología Forense. Slideshare. https://es.slideshare.net/agustinarenas1/la-marihuana-toxicologa-forense-74407203Amaratunga, P., Lorenz, B., & Lemberg, D. (2013). Quantitative measurement of synthetic cathinones in oral fluid. Journal of Analytical Toxicology, 37(9), 622–628. https://doi.org/10.1093/jat/bkt080Andas, H., Krabseth, H. M., Enger, A., Marcussen, B., Haneborg, A. M., Christophersen, A., Vindenes, V., & Øiestad, E. (2014). Detection time for thc in oral fluid after frequent cannabis smoking. Therapeutic Drug Monitoring, 36(6), 808–814. https://doi.org/10.1097/FTD.0000000000000092Angulo, G. B., & Aurora Hernández Sánchez. (2016). Utilidad de las muestras de saliva en el diagnóstico por el laboratorio. Rev Latinoam Patol Clin Med Lab, 63(1), 13–18. www.medigraphic.com/patologiaclinicawww.medigraphic.org.mxwww.medigraphic.org.mxAnizan, S., & Huestis, M. (2012). The Potential Role of Oral Fluid in Antidoping Testing. Nature Medicine, 17(7), 883–887. https://doi.org/10.1373/clinchem.2013.209676.Anizan, S., Milman, G., Desrosiers, N., Barnes, A. J., David, A., & Huestis, M. A. (2014). Oral fluid cannabinoid concentrations following controlled smoked cannabis in chronic frequent and occasional smokers. 405(26), 1–19. https://doi.org/10.1007/s00216-013-7291-5.OralArizan, S., Bergamaschi, M., Barnes, A. J., Milman, G., Desrosiers, N. A., Lee, D., Gorelick, D. A., & Huestis, M. A. (2016). Impact of Oral Fluid Collection Device on Cannabinoid Stability Following Smoked Cannabis. Drug Testing and Analysis, 7(2), 114–120. https://doi.org/10.1002/dta.1688.AHArkell, T. R., Kevin, R. C., Stuart, J., Lintzeris, N., Haber, P. S., Ramaekers, J. G., & McGregor, I. S. (2019). Detection of Δ9 THC in oral fluid following vaporized cannabis with varied cannabidiol (CBD) content: An evaluation of two point-of-collection testing devices. Drug Testing and Analysis, 11(10), 1486–1497. https://doi.org/10.1002/dta.2687Arroyo, A., Mora, A., Sanchez, M., Barbal, M., & Palahi, M. (2011). Times of Detection of Drugs of Abuse in Saliva: Study of Arrested Population. Journal of Forensic Research, 02(01), 10–13. https://doi.org/10.4172/2157-7145.1000114Arroyo Fernández, A., Mora Font, A., Sánchez Fité, M., Barbal Pagés, M., & Palahí Adroher, M. (2010). Drogas de abuso en saliva de conductores: aspectos médico-legales. Revista Española de Medicina Legal, 34(1), 3–10. https://doi.org/10.1016/s0377-4732(08)70020-8Bakke, E., Høiseth, G., Furuhaugen, H., Berg, T., Arnestad, M., & Gjerde, H. (2020). Oral Fluid to Blood Concentration Ratios of Different Psychoactive Drugs in Samples from Suspected Drugged Drivers. Therapeutic Drug Monitoring, 42(5), 795–800. https://doi.org/10.1097/FTD.0000000000000760Barnes, A. J., Scheidweiler, K. B., Kolbrich-Spargo, E. A., Gorelick, D. A., Goodwin, R. S., & Huestis, M. A. (2011). MDMA and metabolite disposition in expectorated oral fluid after controlled oral MDMA administration. Therapeutic Drug Monitoring, 33(5), 602–608. https://doi.org/10.1097/FTD.0b013e3182281975Barquero, M. (2006). Principios y Aplicaciones de la Cromatografía de Gases. Universidad de Costa Rica. https://books.google.com.co/books?id=g3o_PUTmr3wC&printsec=frontcover&dq=cromatografia+de+gases&hl=es-419&sa=X&ved=0ahUKEwiglovJkc_kAhWI1lkKHQdXAbUQ6AEIKTAA#v=onepage&q=cromatografia de gases&f=falseBarwick, V., Morrillas, P., Ellison, S., & Engman, J. (1990). La Adecuación al Uso de los Métodos Analíticos. In Eurachem (Vol. 56, Issue 6).Bassotti, E., Merone, G. M., D’Urso, A., Savini, F., Locatelli, M., Tartaglia, A., Dossetto, P., D’Ovidio, C., & de Grazia, U. (2020). A new LC-MS/MS confirmation method for the determination of 17 drugs of abuse in oral fluid and its application to real samples. Forensic Science International, 312. https://doi.org/10.1016/j.forsciint.2020.110330Bista, S. R., Haywood, A., Norris, R., Good, P., Tapuni, A., Lobb, M., & Hardy, J. (2015). Saliva versus Plasma for Pharmacokinetic and Pharmacodynamic Studies of Fentanyl in Patients with Cancer. Clinical Therapeutics, 37(11), 2468–2475. https://doi.org/10.1016/j.clinthera.2015.09.002Böttcher, M., Lierheimer, S., Peschel, A., & Beck, O. (2019). Detection of heroin intake in patients in substitution treatment using oral fluid as specimen for drug testing. Drug and Alcohol Dependence, 198(February), 136–139. https://doi.org/10.1016/j.drugalcdep.2019.02.011Bruun, L. D., Kjeldstadli, K., Temte, V., Birdal, M., Bachs, L., Langødegård, M., Strand, D. H., Gaare, K. I., Øiestad, E., & Høiseth, G. (2019). Detection time of oxazepam and zopiclone in urine and oral fluid after experimental oral dosing. Journal of Analytical Toxicology, 43(5), 369–377. https://doi.org/10.1093/jat/bky083Bueno, G., & Salazar, J. (2012). Validación del método para el análisis de cocaína, opiaceos y sus principales adulterantes por Cromatografía de gases acoplado a espectrometria de masas (GC-MS), en el Instituto Nacional de Medicina Legal de Ciencias Forenses. In UNIVERSIDAD TECNOLOGICA DE PEREIRA. http://recursosbiblioteca.utp.edu.co/tesisd/textoyanexos/66028423B928.pdfBusardo, F. P., Pichini, S., Pellegrini, M., Montana, A., lo Faro, A. F., Zaami, S., & Graziano, S. (2017). Correlation between Blood and Oral Fluid Psychoactive Drug Concentrations and Cognitive Impairment in Driving under the Influence of Drugs. Current Neuropharmacology, 16(1), 84–96. https://doi.org/10.2174/1570159x15666170828162057Calvin, G., & Roy, K. (2017). Liquid Chromatography. Britannica. https://www.britannica.com/science/chromatography/Liquid-chromatographyCardenas, K. (2012). PERFIL CLÍNICO Y DEMOGRÁFICO DE PACIENTES ATENDIDOS EN LOS SERVICIOS DE URGENCIAS, POR INTOXICACIÓN AGUDA CON SUSTANCIAS PSICOACTIVAS. BOGOTÁ D.C. JULIO 2010 – JUNIO 2011.Universidad Nacional de Colombia.Casadiego Mesa, A. F., & Lastra Bello, S. M. (2015). Cannabis sintético: aspectos toxicológicos, usos clínicos y droga de diseño. Revista de La Facultad de Medicina, 63(3), 501–510. https://doi.org/10.15446/revfacmed.v63n3.47460Chow, A. T. Y., Ng, V. C. H., & Lau, F. L. (2015). Can “oral fluid” be used instead of “urine” for rapid screening of drug of abuse: A prospective pilot study. Hong Kong Journal of Emergency MedicineChristodoulides, N., de La Garza, R., Simmons, G. W., McRae, M. P., Wong, J., Newton, T. F., Smith, R., Mahoney, J. J., Hohenstein, J., Gomez, S., Floriano, P. N., Talavera, H., Sloan, D. J., Moody, D. E., Andrenyak, D. M., Kosten, T. R., Haque, A., & McDevitt, J. T. (2015). Application of programmable bio-nano-chip system for the quantitative detection of drugs of abuse in oral fluids. Drug and Alcohol Dependence, 153, 306–313. https://doi.org/10.1016/j.drugalcdep.2015.04.026Codigo sustantivo del trabajo. (1993). 1(August), 117–125.Concheiro, M., Newmeyer, M., Costa, J. L., Flegel, R., Gorelick, D. A., & Huestis, M. A. (2016). Morphine and Codeine in Oral Fluid after Controlled Poppy Seed Administration Marta. Drug Testing and Analysis, 176(1), 100–106. https://doi.org/10.1002/dta.1742.MorphineCone, E. J., & Huestis, M. A. (2007). Interpretation of oral fluid tests for drugs of abuse. Annals of the New York Academy of Sciences, 1098, 51–103. https://doi.org/10.1196/annals.1384.037Congreso de Colombia. (2002). Ley 734 de 2002. 2002. https://www.alcaldiabogota.gov.co/sisjur/normas/Norma1.jsp?i=4589Congreso de la República de Colombia. (2003). Ley 845 del 2003. Diario Oficial, 2003(45), 10.Corte Constitucional de Colombia. (2019). Sentencia C-253-19. http://www.corteconstitucional.gov.co/relatoria/2019/C-253-19.htmCortez, R. (2000). Cromatografía de gases. SGPWE. http://sgpwe.izt.uam.mx/files/users/uami/jrvc/QA_II/Cromatografia_de_Gases.pdfCoulter, C. A., & Moore, C. M. (2019). Analysis of drugs in oral fluid using LC-MS/MS. In Methods in Molecular Biology (Vol. 1872, pp. 237–259). Humana Press Inc. https://doi.org/10.1007/978-1-4939-8823-5_22Crouch, D. J., Day, J., Baudys, J., & Fatah, A. A. (2005). Evaluation of Saliva/Oral Fluid as an Alternate Drug Testing Specimen. Departament of Justice US. https://www.ojp.gov/pdffiles1/nij/grants/203569.pdfDayong, L., Erin, K., Garry, M., Allan, B., Robert, G., & Huestis, M. A. (2013). Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration? Early Human Development, 83(1), 1–11. https://doi.org/10.1016/j.drugalcdep.2012.10.011de Castro, A., Lendoiro, E., Fernández-Vega, H., López-Rivadulla, M., Steinmeyer, S., & Cruz, A. (2014). Assessment of different mouthwashes on cannabis oral fluid concentrations. Drug Testing and Analysis, 6(10), 1011–1019. https://doi.org/10.1002/dta.1605Decreto 1844. (2018). https://www.funcionpublica.gov.co/eva/gestornormativo/norma.php?i=88843Desrosiers, N. A., Barnes, A. J., Hartman, R. L., Scheidweiler, K. B., Kolbrich-Spargo, E. A., Gorelick, D. A., Goodwin, R. S., & Huestis, M. A. (2013). Oral Fluid and Plasma 3,4-Methylenedioxymethamphetamine (MDMA) and Metabolite Correlation after Controlled Oral MDMA Administration. Anal Bioanal Chem, 405(12), 4067–4076. https://doi.org/10.1007/s00216-013-6848-7.OralDesrosiers, N. A., Ramaekers, J. G., Chauchard, E., Gorelick, D. A., & Huestis, M. A. (2015). Smoked Cannabis’ Psychomotor and Neurocognitive Effects in Occasional and Frequent Smokers. Journal of Analytical Toxicology, 39(4), 251–261. https://doi.org/10.1093/jat/bkv012di Corcia, D., Lisi, S., Pirro, V., Gerace, E., Salomone, A., & Vincenti, M. (2013). Determination of pharmaceutical and illicit drugs in oral fluid by ultra-high performance liquid chromatography-tandem mass spectrometry. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 927, 133–141. https://doi.org/10.1016/j.jchromb.2013.01.025di Fazio, V., Wille, S. M. R., Toennes, S. W., van Wel, J. H. P., Ramaekers, J. G., & Samyn, N. (2018). Driving under the influence of cocaine: Quantitative determination of basic drugs in oral fluid obtained during roadside controls and a controlled study with cocaine users. Drug Testing and Analysis, 10(8), 1285–1296. https://doi.org/10.1002/dta.2379Direccion General de Seguridad Vial. (2015). Programa Control de Drogas. Buenos Aires Argentina. https://www.buenosaires.gob.ar/areas/seguridad_justicia/seguridad_urbana/seguridad_vial/programa_control_drogas.php?menu_id=34134Drummer, O. H. (2016). Drug Testing in Oral Fluid. Psychological Perspectives, 59(4), 524–525. https://doi.org/10.1080/00332925.2016.1240547Dyer, K. R., & Wilkinson, C. (2008). The detection of illicit drugs in oral fluid: Another potential strategy to reduce illicit drug-related harm. Drug and Alcohol Review, 27(1), 99–107. https://doi.org/10.1080/09595230701727583Egea-Mellado, J. M. (2010). Fundamento de la espectrometria de masas en tándem (MS/MS). Sociedad Española de Bioquímica Clínica y Patología Molecular, 1–11.Ellefsen, K., Concheiro, M., Pirard, S., Gorelick, D. A., & Huestis, M. (2016). Oral Fluid Cocaine and Benzoylecgonine Concentrations following Controlled Intravenous Cocaine Administration. Forensic Science International, 260(1), 95–101.El tiempo. (2015). Aumenta consumo de drogas en el trabajo. El Tiempo. https://www.eltiempo.com/archivo/documento/CMS-14674817Fabritius, M., Chtioui, H., Battistella, G., Annoni, J., Dao, K., Favrat, B., Fornari, E., Luer, E., Maeder, P., & Giroud, C. (2013). Comparasion of cannabinoid concentrations in oral fluid and whole blood between occasional and regular cannabis smokers prior to and after smoking a cannabis joint. Anal Bioanal Chem, 405, 9791–9803.Fenoll, C., Muñoz, J., Sanchiz, V., Herreros, B., Hernandez, V., Minguez, M., & Benages, A. (2004). Unstimulated salivary flow rate, pH and buffer capacity of saliva in healthy volunteers. Resvista Española de Enfermedades Digestivas, 96(11), 773–783. https://pdfs.semanticscholar.org/6313/5f811d748f67a5ad01604c19de67d1eb3443.pdfFiorentin, T. R., D’Avila, F. B., Comiran, E., Zamboni, A., Scherer, J. N., Pechansky, F., Borges, P. E. M., Fröehlich, P. E., & Limberger, R. P. (2017). Simultaneous determination of cocaine/crack and its metabolites in oral fluid, urine and plasma by liquid chromatography-mass spectrometry and its application in drug users. Journal of Pharmacological and Toxicological Methods, 86(April), 60–66. https://doi.org/10.1016/j.vascn.2017.04.003Franco, A., Navarro, M., Campos, M., Blumenberg, C., Alves, A., & Paranhos, L. (2020). Assessment of dental age estimation methods applied to Brazilian children a systematic review and metaanalysis DMFR. https://doi.org/10.1259/dmfr.20200128Gainza, I., Nogué, S., Martínez Velasco, C., Hoffman, R. S., Burillo-Putze, G., Dueñas, A., Gómez, J., & Pinillos, M. A. (2003). Intoxicación por drogas. Anales Del Sistema Sanitario de Navarra, 26. https://doi.org/10.4321/s1137-66272003000200006Gaohua, L., Miao, X., & Dou, L. (2021). Crosstalk of physiological pH and chemical pKa under the umbrella of physiologically based pharmacokinetic modeling of drug absorption, distribution, metabolism, excretion, and toxicity. In Expert Opinion on Drug Metabolism and Toxicology (Vol. 17, Issue 9, pp. 1103–1124). Taylor and Francis Ltd. https://doi.org/10.1080/17425255.2021.1951223Garg, U., & Cooley, C. (2019). Testing of Drugs of Abuse in Oral Fluid, Sweat, Hair, and Nail: Analytical, Interpretative, and Specimen Adulteration Issues. In Critical Issues in Alcohol and Drugs of Abuse Testing (Second Edi). Elsevier Inc. https://doi.org/10.1016/b978-0-12-815607-0.00028-9Gjerde, H., Langel, K., Favretto, D., & Verstraete, A. G. (2014). Detection of 4 benzodiazepines in oral fluid as biomarker for presence in blood. Therapeutic Drug Monitoring, 36(2), 252–256. https://doi.org/10.1097/FTD.0b013e3182a3ab42Gobierno de Buenos Aires. (2010). Programa de control de drogas. https://www.buenosaires.gob.ar/areas/seguridad_justicia/seguridad_urbana/seguridad_vial/programa_control_drogas.php?menu_id=34134González-Luque, J. C., & Quintela-Jorge, O. (2011). La determinación de drogas en fluido oral en conductores de vehículos: ¿se abre el camino a la intervención preventiva? Rev Esp Drogodep, 36(3), 341–350.Griswold, M. K., Chai, P. R., Krotulski, A. J., Friscia, M., Chapman, B. P., Varma, N., Boyer, E. W., Logan, B. K., & Babu, K. M. (2017). A Novel Oral Fluid Assay (LC-QTOF-MS) for the Detection of Fentanyl and Clandestine Opioids in Oral Fluid After Reported Heroin Overdose. Journal of Medical Toxicology, 13(4), 287–292. https://doi.org/10.1007/s13181-017-0632-6Hartman, R. L., Brown, T. L., Milavetz, G., Spurgin, A., Gorelick, D. A., Gaffney, G., & Huestis, M. A. (2016). Controlled vaporized cannabis, with and without alcohol: subjective effects and oral fluid-blood cannabinoid relationships. Drug Testing and Analysis, 8(7), 690–701. https://doi.org/10.1002/dta.1839Heltsley, R., DePriest, A., Black, D. L., Crouch, D. J., Robert, T., Marshall, L., Meadors, V. M., Caplan, Y. H., & Cone, E. J. (2012). Oral fluid drug testing of chronic pain patients. II. Comparison of paired oral fluid and urine specimens. Journal of Analytical Toxicology, 36(2), 75–80. https://doi.org/10.1093/jat/bkr019Hofman, L. F. (2001). Human Saliva as a Diagnostic Specimen. The Journal of Nutrition, 131(5), 1621S-1625S. https://doi.org/10.1093/jn/131.5.1621SIDEAM. (2021). Instructivo de confirmación o validación de métodos analíticos. 2013–2015. http://sgi.ideam.gov.co/documents/412030/35488871/M-S-LC-I038+INSTRUCTIVO+DE+CONFIRMACIÓN+O+VALIDACIÓN+DE+MÉTODOS+ANALÍTICOS+v3.pdf/cd82e785-16f2-4ffa-b965-4614a9808f38?version=1.0Instituto Nacional de Medicina Legal y Ciencias Forenses. (2015). Guía para la determinación clínica forense del estado de embriaguez aguda. 91. http://www.medicinalegal.gov.co/documents/20143/40473/Guía+para+la+determinación+clínica+forense+delestado+de+embriaguez+aguda.pdf/8de54a98-38db-f7c1-e04c-9b2505b585e9J.M, A., Diaz, J., Castello, J., Fabregat, A., & Lopez, P. (2002). Drogas de abuso: evaluación de las unidades de conductas adictivas en un Área Sanitaria. Revista de Diagnóstico Biológico, 51(2). https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0034-79732002000200005Kaufman, E., & Lamster, I. B. (2002). The diagnostic applications of Saliva A Review. Critical Reviews in Oral Biology & Medicine, 13(2), 197–212. https://doi.org/10.1177/154411130201300209Krotulski, A. J., Mohr, A. L. A., Friscia, M., & Logan, B. K. (2018). Field Detection of Drugs of Abuse in Oral Fluid Using the Alere DDS2 Mobile Test System with Confirmatios by Liquids Chromatography Tandem Mass Spectrometry (LC-MS/MS). Jorunal of Analytical Toxicology, 170–175.K.Wolff, M. Farrell, J.Marsden, M. G. Monteiro, R. Ali, S. W. y J. S. (2001). Revisión de los indicadores biológicos de uso ilegal de drogas, consideraciones prácticas y utilidad clínica. Revista de Toxicomanías, 28. http://www.cat-barcelona.com/app/webroot/uploads/rets/RET28_1.pdfLangel, K., Gjerde, H., Favretto, D., Lillsunde, P., Øiestad, E. L., Ferrara, S. D., & Verstraete, A. G. (2014). Comparison of drug concentrations between whole blood and oral fluid. Drug Testing and Analysis, 6(5), 461–471. https://doi.org/10.1002/dta.1532Langel, K., Gunnar, T., Ariniemi, K., Rajamäki, O., & Lillsunde, P. (2011). A validated method for the detection and quantitation of 50 drugs of abuse and medicinal drugs in oral fluid by gas chromatography-mass spectrometry. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 879(13–14), 859–870. https://doi.org/10.1016/j.jchromb.2011.02.027Lee, D., Milman, G., Barnes, A. J., Goodwin, R. S., Hirvonen, J., & Huestis, M. A. (2011). Oral fluid cannabinoids in chronic, daily cannabis smokers during sustained, monitored abstinence. Clinical Chemistry, 57(8), 1127–1136. https://doi.org/10.1373/clinchem.2011.164822Lee, D., Milman, G., Schwope, D. M., Barnes, A. J., Gorelick, D. A., & Huestis, M. A. (2012). Cannabinoid Stability in Authentic Oral Fluid after Controlled Cannabis Smoking. Clinical Chemistry, 23(1), 1–7. https://doi.org/10.1373/clinchem.2012.184929.CannabinoidLee, D., Schwope, D. M., Milman, G., Barnes, A. J., Gorelick, D. A., & Huestis, M. A. (2012). Cannabinoid Disposition in Oral Fluid after Controlled Smoked Cannabis. Clinical Chemistry, 23(1), 1–7. https://doi.org/10.1373/clinchem.2011.177881.CannabinoidLee, D., Vandrey, R., Milman, G., Bergamaschi, M., Mendu, D. R., Murray, J. A., Barnes, A. J., & Huestis, M. A. (2013). Oral fluid/plasma cannabinoid ratios following controlled oral THC and smoked cannabis administration. Anal Bioanal Chem, 405(23), 7269–7279. https://doi.org/10.1007/s00216-013-7159-8.OralLey 769 de 2002. (2002). http://www.secretariasenado.gov.co/senado/basedoc/ley_0769_2002.htmlLogan, B. K., D’Orazio, A. L., Mohr, A. L. A., Limoges, J. F., Miles, A. K., Scarneo, C. E., Kerrigan, S., Liddicoat, L. J., Scott, K. S., & Huestis, M. A. (2018). Recommendations for toxicological investigation of drug-impaired driving and motor vehicle fatalities-2017 update. Journal of Analytical Toxicology, 42(2), 63–68. https://doi.org/10.1093/jat/bkx082Logan, B. K., Mohr, A. L. A., & Talpins, S. K. (2014). Detection and prevalence of drug use in arrested drivers using the dräger drug test 5000 and affiniton DrugWipe oral fluid drug screening devices. Journal of Analytical Toxicology, 38(7), 444–450. https://doi.org/10.1093/jat/bku050López V, A., Aroche A., A., & Romero, B. R. (2010). Uso y abuso de las benzodiacepinas. MEDISAN, 14(4), 555–566.Lund, H. M. E., Øiestad, E. L., Gjerde, H., & Christophersen, A. S. (2011). Drugs of abuse in oral fluid collected by two different sample kits - Stability testing and validation using ultra performance tandem mass spectrometry analysis. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 879(30), 3367–3377. https://doi.org/10.1016/j.jchromb.2011.09.002MacCall, C. A., Ritchie, G., & Sood, M. (2013). Oral fluid testing as an alternative to urine testing for drugs of abuse in inpatient forensic settings: Giving patients choice. Scottish Medical Journal, 58(2), 99–103. https://doi.org/10.1177/0036933013482640Mateu-Gelabert, P., Friedman, S., & Sandoval, M. (2007). Éxtasis (3,4-metilendioximetanfetamina, MDMA): aspectos farmacológicos, clínicos y criminológicos. Trastornos Adictivos, 9(4), 260–268. http://www.ncbi.nlm.nih.gov/pubmed/21915175Miller, B., Kim, J., & Concheiro, M. (2017). Stability of synthetic cathinones in oral fluid samples. Forensic Science International, 274, 13–21. https://doi.org/10.1016/j.forsciint.2016.11.034Milman, G., Schwope, D. M., Schwilke, E. W., Darwin, W. D., Deanna, L., Goodwin, R. S., Gorelick, D. A., & Huestis, M. A. (2013). Oral Fluid and Plasma Cannabinoid Ratios after Around-the- Clock Controlled Oral Δ9-Tetrahydrocannabinol Administration. Clinical Chemistry, 57(11). https://doi.org/10.1373/clinchem.2011.169490.OralMoore, C. (2011). Oral fluid and hair in workplace drug testing programs: New technology for immunoassays. Drug Testing and Analysis, 3(3), 166–168. https://doi.org/10.1002/dta.140Moore, C., Coulter, C., Uges, D., Tuyay, J., van der Linde, S., van Leeuwen, A., Garnier, M., & Orbita, J. (2011). Cannabinoids in oral fluid following passive exposure to marijuana smoke. Forensic Science International, 212(1–3), 227–230. https://doi.org/10.1016/j.forsciint.2011.06.019Musshoff, F., Hokamp, E. G., Bott, U., & Madea, B. (2014). Performance evaluation of on-site oral fluid drug screening devices in normal police procedure in Germany. Forensic Science International, 238, 120–124. https://doi.org/10.1016/j.forsciint.2014.02.005National Conference Of State Legislatures. (2021). States Explore Oral Fluid Testing to Combat Impaired Driving. https://www.ncsl.org/research/transportation/states-explore-oral-fluid-testing-to-combat-impaired-driving.aspxNCI thesaurus. (2022). Cocaine. https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=NCI_Thesaurus&code=C80153Newmeyer, M., Concheiro, M., Costa, J. L., Flegel, R., Gorelick, D. A., & Huestis, M. A. (2016). Oral Fluid with Three Modes of Collection and Plasma Methamphetamine and Amphetamine Enantiomer Concentrations After Controlled Intranasal l-Methamphetamine Administration Matthew. Drug Testing and Analysis, 176(3), 139–148. https://doi.org/10.1002/dta.1784.Newmeyer, M., Desrosiers, N., Dayong, L., Mendu, D., BBarnes, A., Gorelick, D. A., & Hue. (2014). Cannabinoid Disposition in Oral Fluid after Controlled Cannabis Smoking in Frequent and Occasional Smokers. Drug and Alcohol Review, 23(1), 1–7. https://doi.org/10.1002/dta.1632.Nichterwitz, J., Fiorentin, T., Viera, T., Pereira, R., & Pechansky, F. (2017). Oral fluid testing for cocaine: Analytical evaluation of two point-of-collection drug screening Devices. Journal of Analytical Toxicology, 41(5), 392–398. https://doi.org/10.1093/jat/bkx018Nordal, K., Øiestad, E. L., Enger, A., Christophersen, A. S., & Vindenes, V. (2015). Detection Times of Diazepam, Clonazepam, and Alprazolam in Oral Fluid Collected from Patients Admitted to Detoxification, after High and Repeated Drug Intake. Therapeutic Drug Monitoring, 37(4), 451–460. https://doi.org/10.1097/FTD.0000000000000174NZ Drug Foundation. (2022). New drug-driving law ignores science, targets poor . https://www.drugfoundation.org.nz/matters-of-substance/new-drug-driving-law-ignores-science-targets-poor/Observatorio de drogas de Colombia. (2017). Reporte de Drogas en Colombia. http://www.odc.gov.co/Portals/1/publicaciones/pdf/odc-libro-blanco/reporte_drogas_colombia_2017.pdfObservatorio Nacional de Seguridad Vial. (2017). La embriaguez al conducir, descripcion de una problematica vigente en Colombia. https://ansv.gov.co/observatorio/public/documentos/embriaguez 2017 - bavaria (jun_2018_final).pdfOECD (2010). Drugs and Driving Detection and Deterrence. https://www.itf-oecd.org/sites/default/files/docs/10drugs.pdfOrganización Panamericana de la Salud. (2022). Abuso de sustancias. https://www.paho.org/es/temas/abuso-sustanciasOspina, L. (1994). El método de análisis para los estudios de estabilidad y de biodisponibilidad de medicamentos. Parte I. Revista Colombiana de Ciencias Quimico-Farmaceuticas, 22.Palmela Pereira, C. (2014). A importância médico-legal e criminalística da saliva: Sistematização da sua aplicação nas ciências forenses. Revista Portuguesa de Estomatologia, Medicina Dentaria e Cirurgia Maxilofacial, 55(1), 3–6. https://doi.org/10.1016/j.rpemd.2014.01.002Papaseit, E., Olesti, E., Pérez-Mañá, C., Torrens, M., Fonseca, F., Grifell, M., Ventura, M., de la Torre, R., & Farré, M. (2021). Acute pharmacological effects of oral and intranasal mephedrone: An observational study in humans. Pharmaceuticals, 14(2), 1–13. https://doi.org/10.3390/ph14020100Pehrsson, A., Blencowe, T., Vimpari, K., Langel, K., Engblom, C., & Lillsunde, P. (2011). An evaluation of on-site oral fluid drug screening devices drugwipe® 5+ and rapid STAT® using oral fluid for confirmation analysis. Journal of Analytical Toxicology, 35(4), 211–218. https://doi.org/10.1093/anatox/35.4.211Petrides, A. K., Melanson, S. E. F., Kantartjis, M., Le, R. D., Demetriou, C. A., & Flood, J. G. (2018). Monitoring opioid and benzodiazepine use and abuse: Is oral fluid or urine the preferred specimen type? Clinica Chimica Acta, 481(December 2017), 75–82. https://doi.org/10.1016/j.cca.2018.02.034Pichini, S., Altieri, I., Zuccaro, P., & Pacifici, R. (1996). Drug monitoring in nonconventional biological fluids and matrices. Clinical Pharmacokinetics, 30(3), 211–228. https://doi.org/10.2165/00003088-199630030-00003Pinzon, A. (2015). Aspectos técnicos y científicos de las pruebas de campo para la detección de sustancias psicoactivas aplicadas a conductores de vehículos autmotores. Instituto Nacional de medicina legal y ciencias forenses. https://www.medicinalegal.gov.co/documents/20143/49508/Art%C3%ADculos%C2%B7Complementarios.pdfPoyatos, L., Papaseit, E., Olesti, E., Pérez-Mañá, C., Ventura, M., Carbón, X., Grifell, M., Fonseca, F., Torrens, M., de la Torre, R., & Farré, M. (2021). A comparison of acute pharmacological effects of methylone and mdma administration in humans and oral fluid concentrations as biomarkers of exposure. In Biology (Vol. 10, Issue 8). https://doi.org/10.3390/biology10080788PubChem. (2015a). Alprazolam. National Center for Biotechnology Information. https://pubchem.ncbi.nlm.nih.gov/compound/2118#section=Metabolism-MetabolitesPubchem. (2015). Cocaine. National Center for Biotechnology Information. https://pubchem.ncbi.nlm.nih.gov/compound/446220PubChem. (2015b). Dronabidol. National Center for Biotechnology Information. https://pubchem.ncbi.nlm.nih.gov/compound/16078Puy, C. L. (2006). La saliva en el mantenimiento de la salud oral y como ayuda en el diagnóstico de algunas patologías. Medicina Oral, Patología Oral y Cirugía Bucal (Internet), 11(5), 449–455.Ramos Maya, A. (2017). Proyecto de Ley 167 del 2017 (Issue 3). http://leyes.senado.gov.co/proyectos/index.php/textos-radicados-senado/p-ley-2017-2018/1059-proyecto-de-ley-167-de-2017Rocchi, R., Simeoni, M. C., Montesano, C., Vannutelli, G., Curini, R., Sergi, M., & Compagnone, D. (2018). Analysis of new psychoactive substances in oral fluids by means of microextraction by packed sorbent followed by ultra-high-performance liquid chromatography–tandem mass spectrometry. Drug Testing and Analysis, 10(5), 865–873. https://doi.org/10.1002/dta.2330ROSITA. (2018a). Retriever September 26, 2019, from http://www.rosita.org/success-program-random-roadside-testing/ROSITA. (2018b). Retriever September 26, 2019, from http://www.rosita.org/better-reliable-roadside-drug-test/Saar-Reismaa, P., Erme, E., Vaher, M., Kulp, M., Kaljurand, M., & Mazina-Šinkar, J. (2018). In Situ Determination of Illegal Drugs in Oral Fluid by Portable Capillary Electrophoresis with Deep UV Excited Fluorescence Detection. Analytical Chemistry, 90(10), 6253–6258. https://doi.org/10.1021/acs.analchem.8b00911Sanchez Martinez, P. (2013). La saliva como fluido diagnóstico. Enfermedades Hepáticas Autoinmunes, 7(Unidad de Inmunología, Facultad de Medicina, Universidad de Granada, Granada), 44–52.Scherer, J. N., Fiorentin, T. R., Borille, B. T., Pasa, G., Sousa, T. R. V., von Diemen, L., Limberger, R. P., & Pechansky, F. (2017). Reliability of point-of-collection testing devices for drugs of abuse in oral fluid: A systematic review and meta-analysis. Journal of Pharmaceutical and Biomedical Analysis, 143, 77–85. https://doi.org/10.1016/j.jpba.2017.05.021Schulze, H., Schumacher, M., Urmeew, R., Alvarez, J., Bernhoft, I. M., de Gier, H. G., Hagenzieker, M., Houwing, S., Knoche, A., & Pilgerstorfer, M. (2012). Driving Under the Influence of Drugs, Alcohol and Medicines in Europe—findings from the DRUID project. 1–58.Shafi, A., Berry, A. J., Sumnall, H., Wood, D. M., & Tracy, D. K. (2020). New psychoactive substances: a review and updates. Therapeutic Advances in Psychopharmacology, 10, 204512532096719. https://doi.org/10.1177/2045125320967197Sobczak, L., & Gorynski, K. (2021). Evaluation of swabs form 15 commercially available oral fluid sample collection devices for the analysis of commonly aused substances: doping agents and drugs of abuse. The Royal Society of Chemistry, 145, 7279–7288.Spindle, T. R., Cone, E. J., Herrmann, E. S., Mitchell, J. M., Flegel, R., LoDico, C., Bigelow, G. E., & Vandrey, R. (2020). Pharmacokinetics of cannabis brownies: A controlled examination of Δ9-tetrahydrocanna-binol and metabolites in blood and oral fluid of healthy adult males and females. Journal of Analytical Toxicology, 44(7), 661–671. https://doi.org/10.1093/jat/bkaa067Spindle, T. R., Cone, E. J., Schlienz, N. J., Mitchell, J. M., Bigelow, G. E., Flegel, R., Hayes, E., & Vandrey, R. (2019). Acute pharmacokinetic profile of smoked and vaporized cannabis in human blood and oral fluid. Journal of Analytical Toxicology, 43(4), 233–258. https://doi.org/10.1093/jat/bky104Swortwood, M., Newmeyer, M., Andersson, M., Abulseud, O., Scheidweiler, K. B., & Huestis, M. A. (2017). Cannabinoid disposition in oral fluid after controlled smoked, vaporized, and oral cannabis administration. Drug Testing and Analysis, 176(3), 139–148. https://doi.org/10.1002/dta.2092Tang, M. H. Y., Ching, C. K., Poon, S., Chan, S. S. S., Ng, W. Y., Lam, M., Wong, C. K., Pao, R., Lau, A., & Mak, T. W. L. (2018). Evaluation of three rapid oral fluid test devices on the screening of multiple drugs of abuse including ketamine. Forensic Science International, 286, 113–120. https://doi.org/10.1016/j.forsciint.2018.03.004Téllez, J. (2013). Marihuana cannabis: aspectos toxicológicos, clínicos, sociales y potenciales usos terapéuticos. In Journal of Chemical Information and Modeling (Vol. 53, Issue 9). https://doi.org/10.1017/CBO9781107415324.004Toennes, S. W., Geraths, A., Pogoda, W., Paulke, A., Wunder, C., Theunissen, E. L., & Ramaekers, J. G. (2018). Pharmacokinetic properties of the synthetic cannabinoid JWH-018 in oral fluid after inhalation. Drug Testing and Analysis, 10(4), 644–650. https://doi.org/10.1002/dta.2310Toennes, S. W., Schneider, D., Pogoda, W., Paulke, A., Wunder, C., Theunissen, E. L., Kuypers, K. P. C., de Sousa Fernandes Perna, E., & Ramaekers, J. G. (2019). Pharmacokinetic properties of 4-fluoroamphetamine in serum and oral fluid after oral ingestion. Drug Testing and Analysis, 11(7), 1028–1034. https://doi.org/10.1002/dta.2595Trana, A. di, Mannocchi, G., Pirani, F., Maida, N. la, Via, S., Cooperazione, D., & Addiction, C. (2020). A Comprehensive HPLC – MS-MS Screening Method for 77 New Psychoactive Substances , 24 Classic Drugs and 18 Related Metabolites in Blood , Urine and Oral Fluid. Department of Excellence of Biomedical Sciences and Public Health.Truver, M. T., Palmquist, K. B., & Swortwood, M. J. (2019). Oral fluid and drug impairment: Pairing toxicology with drug recognition expert observations. Journal of Analytical Toxicology, 43(8), 637–643. https://doi.org/10.1093/jat/bkz075United Nations. (2021). Informe Mundial de Drogas. In World Drug Report 2021. https://www.unodc.org/res/wdr2021/field/WDR21_Booklet_2.pdfUNODC. (2017). Resumen informe mundial sobre las drogas 2017. https://www.unodc.org/wdr2017/field/WDR_Booklet1_Exsum_Spanish.pdfUNODC. (2021). What are NPS? https://www.unodc.org/LSS/Page/NPSUribe Granja, C., Saavedra, M. Á., Almarales Navarro, J. R., Cabezas Pulido, L. E., & Soto Bohórquez, P. V. (2012). Accidentalidad vial por consumo de drogas y alcohol: estado actual. Revista Repertorio de Medicina y Cirugía, 21(2), 79–86. https://doi.org/10.31260/repertmedcir.v21.n2.2012.800Valen, A., Leere Øiestad, Å. M., Strand, D. H., Skari, R., & Berg, T. (2017). Determination of 21 drugs in oral fluid using fully automated supported liquid extraction and UHPLC-MS/MS. Drug Testing and Analysis, 9(5), 808–823. https://doi.org/10.1002/dta.2045Vandrey, R., Herrmann, E. S., Mitchell, J. M., Bigelow, G. E., Flegel, R., LoDico, C., & Cone, E. J. (2017). Pharmacokinetic profile of oral cannabis in humans: Blood and oral fluid disposition and relation to pharmacodynamic outcomes. Journal of Analytical Toxicology, 41(2), 83–99. https://doi.org/10.1093/jat/bkx012Vanstechelman, S., Isalberti, C., van der Linden, T., Pil, K., Legrand, S. A., & Verstraete, A. G. (2012). Analytical evaluation of four on-site oral fluid drug testing devices. Journal of Analytical Toxicology, 36(2), 136–140. https://doi.org/10.1093/jat/bkr016Verstraete, A., & Ghent University. (2010). Roadside Testing Assessment. The Cambridge Companion to Bunyan, 1–10. https://doi.org/10.1017/CCOL9780521515269.001VIM. (2012). Vocabulario Internacional de Metrologia Conceptos fundamentales y generales, y terminos asociados. Journal of the American Chemical Society, 54(2), 580–583. https://doi.org/10.1021/ja01341a021Vindenes, V., Lund, H. M. E., Andresen, W., Gjerde, H., Ikdahl, S. E., Christophersen, A. S., & Øiestad, E. L. (2012). Detection of drugs of abuse in simultaneously collected oral fluid, urine and blood from Norwegian drug drivers. Forensic Science International, 219(1–3), 165–171. https://doi.org/10.1016/j.forsciint.2012.01.001Vindenes, V., Strand, D. H., Koksæter, P., & Gjerde, H. (2016). Detection of nitrobenzodiazepines and their 7-amino metabolites in oral fluid. Journal of Analytical Toxicology, 40(4), 310–312. https://doi.org/10.1093/jat/bkw020Vindenes, V., Yttredal, B., Oiestad, E., Waal, H., & Bernard, J. (2011). Oral fluid is aviable alternative for monitoring drug abuse: Detection of drugs in oral fluid by liquid chromatography-tandem mass spectrometry and comparison to the results from urine samples from patients treated with methadone or buprenorphine. Journal of Analytical Toxicology, 35(1), 32–39.Vizcaino, G. (2017). Importancia del calculo de la sensibilidad, especificidad y otros parámetros estadísticos en el uso de las pruebas de diagnostico clínico y laboratorio. Medicina y Laboratorio, 23(7–8), 365–386. http://docs.bvsalud.org/biblioref/2018/05/883697/importancia-calculo-sensibilidad-y-especifidad.pdfZaragoza Meneses, Ma. T. de J. (2018). La saliva. Auxiliar de diagnóstico. In La saliva. Auxiliar de diagnóstico. https://doi.org/10.22201/fesz.9786070299780e.2018EstudiantesInvestigadoresMaestrosPúblico generalORIGINAL1026581820.2022.pdf1026581820.2022.pdfTesis de Maestría en Toxicologíaapplication/pdf1630694https://repositorio.unal.edu.co/bitstream/unal/81634/1/1026581820.2022.pdfa428bdf1822ae6a10e585967106d51c6MD51LICENSElicense.txtlicense.txttext/plain; charset=utf-84074https://repositorio.unal.edu.co/bitstream/unal/81634/2/license.txt8153f7789df02f0a4c9e079953658ab2MD52THUMBNAIL1026581820.2022.pdf.jpg1026581820.2022.pdf.jpgGenerated Thumbnailimage/jpeg4792https://repositorio.unal.edu.co/bitstream/unal/81634/3/1026581820.2022.pdf.jpg26c391958f84ae6b2bd16c358278265aMD53unal/81634oai:repositorio.unal.edu.co:unal/816342023-08-05 23:04:03.998Repositorio Institucional Universidad Nacional de Colombiarepositorio_nal@unal.edu.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